SVB Financial Group
- SEC CIK
- 0000719739
- Latest filing
- Nov 10, 2025
Holdings changes from Q2 2023 to Q3 2023
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 0
- Added
- 1
- Est. +$1.30K
- Reduced
- 4
- Est. −$1.72M
- Sold out
- 3
- Est. −$1.08M
Portfolio value went from $52.9M to $53.2M (+$251.3K (+0.5%)); positions from 24 to 21 (−3).
All Q3 2023 holdingsAll Q2 2023 holdings
In the shares, value and % of portfolio columns, the top figure is Q3 2023 and the gray one below is Q2 2023. For stocks that split between the two quarters, Q2 2023 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| COINCoinbase Global, Inc. | UnchangedHistory | 406,973406,973 | 00.0% | $30.6M$29.1M | $0 | 57.5%55.0% | +2.44 |
| ROOTRoot, Inc. | UnchangedHistory | 783,012783,012 | 00.0% | $7.45M$7.00M | $0 | 14.0%13.2% | +0.78 |
| OKTAOkta, Inc. | ReducedHistory | 79,15299,872 | −20,720−20.7% | $6.45M$6.93M | −$1.69M | 12.1%13.1% | −0.95 |
| AXSMAxsome Therapeutics, Inc. | UnchangedHistory | 33,84933,849 | 00.0% | $2.37M$2.43M | $0 | 4.5%4.6% | −0.15 |
| GPCRStructure Therapeutics Inc. | UnchangedHistory | 35,35335,353 | 00.0% | $1.78M$1.47M | $0 | 3.4%2.8% | +0.58 |
| OBIOOrchestra BioMed Holdings, Inc. | UnchangedHistory | 127,068127,068 | 00.0% | $1.11M$889.5K | $0 | 2.1%1.7% | +0.40 |
| MLTXMoonLake Immunotherapeutics | UnchangedHistory | 16,17316,173 | 00.0% | $921.9K$824.8K | $0 | 1.7%1.6% | +0.18 |
| ROVRRover Group, Inc. | UnchangedHistory | 105,534105,534 | 00.0% | $660.6K$518.2K | $0 | 1.2%1.0% | +0.26 |
| CMAXCareMax, Inc. | UnchangedHistory | 300,000300,000 | 00.0% | $636.0K$933.0K | $0 | 1.2%1.8% | −0.57 |
| PLPlanet Labs PBC | UnchangedHistory | 172,097172,097 | 00.0% | $447.5K$554.2K | $0 | 0.8%1.0% | −0.21 |
| GLBEGlobal-E Online Ltd. | UnchangedHistory | 5,1145,114 | 00.0% | $203.2K$209.4K | $0 | 0.4%0.4% | −0.01 |
| CGEMCullinan Therapeutics, Inc. | UnchangedHistory | 13,51613,516 | 00.0% | $122.3K$145.4K | $0 | 0.2%0.3% | −0.04 |
| CRBUCaribou Biosciences, Inc. | UnchangedHistory | 20,71420,714 | 00.0% | $99.0K$88.0K | $0 | 0.2%0.2% | +0.02 |
| GBIOGeneration Bio Co. | ReducedHistory | 25,03427,882 | −2,848−10.2% | $94.9K$153.4K | −$10.8K | 0.2%0.3% | −0.11 |
| PACBPacific Biosciences of California, Inc. | UnchangedHistory | 10,24910,249 | 00.0% | $85.6K$136.3K | $0 | 0.2%0.3% | −0.10 |
| FIRYFiry Inc. | AddedHistory | 13,95013,696 | +254+1.9% | $71.1K$124.6K | +$1.30K | 0.1%0.2% | −0.10 |
| KLRSKalaris Therapeutics, Inc. | ReducedHistory | 17,20725,811 | −8,604−33.3% | $37.0K$87.8K | −$18.5K | 0.1%0.2% | −0.10 |
| MVLAMovella Holdings Inc. | UnchangedHistory | 55,52855,528 | 00.0% | $29.8K$118.3K | $0 | 0.1%0.2% | −0.17 |
| VEROVenus Concept Inc. | UnchangedHistory | 10,66710,667 | 00.0% | $20.9K$22.7K | $0 | <0.1%<0.1% | 0.00 |
| ELDNEledon Pharmaceuticals, Inc. | ReducedHistory | 13,47218,025 | −4,553−25.3% | $18.5K$24.7K | −$6.24K | <0.1%<0.1% | −0.01 |
| MKULMolekule Group, Inc. | UnchangedHistory | 21,24721,247 | 00.0% | $3.08K$49.7K | $0 | <0.1%0.1% | −0.09 |
| DICEDICE Therapeutics, Inc. | Sold outHistory | 021,799 | −21,799−100.0% | $0$1.01M | −$1.01M | 0.0%1.9% | −1.91 |
| PRDSPardes Biosciences, Inc. | Sold outHistory | 035,923 | −35,923−100.0% | $0$65.0K | −$65.0K | 0.0%0.1% | −0.12 |
| GRNAGreenLight Biosciences Holdings, PBC | Sold outHistory | 016,950 | −16,950−100.0% | $0$5.08K | −$5.08K | 0.0%<0.1% | −0.01 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.